Agios finally wins approval for Aqvesme in thalassemianews2025-12-24T13:03:04+00:00December 24th, 2025|Endpoints News|
Sanofi to buy hepatitis B vaccine maker Dynavax for $2.2B; gets CRL for MS drugnews2025-12-24T12:11:48+00:00December 24th, 2025|Endpoints News|
Drugmakers with White House pricing deals may skirt new Medicare demosnews2025-12-23T18:57:02+00:00December 23rd, 2025|Endpoints News|
Gilead’s herpes deal; FDA approvals for Boehringer, Rochenews2025-12-23T14:46:06+00:00December 23rd, 2025|Endpoints News|
Labcorp backs Cellens in developing physics test aimed at bladder cancernews2025-12-23T14:00:11+00:00December 23rd, 2025|Endpoints News|
Neurocrine’s Ingrezza flunks pivotal study in dyskinetic cerebral palsynews2025-12-23T13:28:14+00:00December 23rd, 2025|Endpoints News|
Pfizer discloses patient death in Hympavzi hemophilia trialnews2025-12-23T12:00:08+00:00December 23rd, 2025|Endpoints News|
Novo Nordisk eyes a strong launch with FDA approval of obesity pillnews2025-12-22T23:54:53+00:00December 22nd, 2025|Endpoints News|
CMS proposes two long-awaited Medicare drug pricing demosnews2025-12-22T19:16:42+00:00December 22nd, 2025|Endpoints News|
China’s new commercial insurance model could broaden access to Alzheimer’s drugsnews2025-12-22T18:18:09+00:00December 22nd, 2025|Endpoints News|
